PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 3, 2022Cancer Epidemiology Biomarkers & Prevention32 citationsOpen Access

Racial Disparities in Prostate Cancer: Evaluation of Diet, Lifestyle, Family History, and Screening Patterns

Structured PICO

Does race affect prostate cancer incidence and mortality in men?

P
Population
47,679 men in the Health Professionals Follow-up Study (HPFS)
I
Intervention
African-American or Asian-American race (exposure)
C
Comparator
White race
O
Outcome
Prostate cancer incidence and mortalityhard clinical

African-American men have a significantly higher risk of prostate cancer incidence and mortality that is not fully explained by lifestyle, diet, family history, or PSA screening.

Abstract

BACKGROUND: Racial disparities in prostate cancer incidence and mortality rates are considerable. We previously found in the Health Professionals Follow-up Study (HPFS) that African-American men had an 80% higher prostate cancer risk than White men. With 21 additional years of follow-up and four-fold increase in cases, we undertook a contemporary analysis of racial differences in prostate cancer incidence and mortality in HPFS. METHODS: For 47,679 men, we estimated HRs and 95% confidence intervals (CI) for the association between race and risk of prostate cancer through 2016 using Cox proportional hazards regression. Multivariable models (mHR) were adjusted for lifestyle, diet, family history, and PSA screening collected on biennial questionnaires. RESULTS: 6,909 prostate cancer cases were diagnosed in White, 89 in African-American, and 90 in Asian-American men. African-Americans had higher prostate cancer incidence (mHR = 1.31; 95% CI, 1.06-1.62) and mortality (mHR = 1.67; 95% CI, 1.00-2.78), and lower PSA screening prevalence than White men. The excess risk was greater in the pre-PSA screening era (HR = 1.68; 95% CI, 1.14-2.48) than the PSA screening era (HR = 1.20; 95% CI, 0.93-1.56). Asian-Americans had lower prostate cancer risk (mHR = 0.74; 95% CI, 0.60-0.92), but similar risk of fatal disease compared with white men. CONCLUSIONS: Racial differences in prostate cancer incidence and mortality in HPFS are not fully explained by differences in lifestyle, diet, family history, or PSA screening. IMPACT: Additional research is necessary to address the disproportionately higher rates of prostate cancer in African-American men.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

A 2022 study studied this question.

synapsesocial.com/papers/6a805b4e9b5ec1a880470e08https://doi.org/10.1158/1055-9965.epi-21-1064
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Differences in prognostic factors and survival among white and Asian men with prostate cancer, California, 1995–20042007 · 75 citations
  2. 2Gleason Score and Lethal Prostate Cancer: Does 3 + 4 = 4 + 3?2009 · 397 citations
  3. 3Racial Disparities in the Presentation, Early Definitive Surgical Treatment, and Mortality Among Men Diagnosed with Poorly Differentiated/Undifferentiated Non-metastatic Prostate Cancer in the USA2018 · 10 citations
  4. 4Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array2013 · 551 citations
  5. 5Case-Control Studies of Prostate Cancer in Blacks and Whites in Southern California1987 · 239 citations